Cancer Incidence and Mortality for Wyoming County, 2015-2019

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 288.8 543.8 515.2-573.7 158.0 591.9 549.7-636.7 130.8 517.9 476.9-561.7 86.0 162.5 147.2-179.0 45.2 184.3 160.2-211.3 40.8 149.2 128.9-172.1
Oral cavity and pharynx 7.6 13.4 9.4-18.8 5.2 18.3 11.7-27.5 2.4 8.7 4.4-16.1 1.4 2.4 1.0-5.4 1.2 4.7 1.6-10.8 0.2 0.6 0.0-5.0
Esophagus 3.0 5.1 2.8-8.9 2.2 7.3 3.5-13.8 0.8 3.0 0.8-8.6 2.4 4.4 2.2-8.0 1.8 7.0 3.1-14.0 0.6 2.0 0.4-7.0
Stomach 4.4 7.9 4.9-12.4 3.8 13.7 8.1-22.0 0.6 2.1 0.4-7.2 1.0 1.7 0.5-4.4 0.8 2.4 0.6-7.1 0.2 0.8 0.0-5.5
Colorectal 21.2 42.9 34.9-52.3 11.6 45.2 34.0-59.2 9.6 40.6 29.3-54.9 5.2 10.5 6.7-15.7 2.8 11.4 6.0-19.8 2.4 9.3 4.6-17.2
Colon excluding rectum 12.6 25.6 19.5-33.1 6.0 24.1 16.0-35.1 6.6 26.6 17.9-38.4 3.6 7.0 4.1-11.4 1.8 7.0 3.1-13.9 1.8 6.9 2.9-14.2
Rectum & rectosigmoid 8.6 17.3 12.4-23.7 5.6 21.1 13.9-31.2 3.0 13.9 7.5-23.8 1.6 3.4 1.4-7.1 1.0 4.5 1.3-10.9 0.6 2.4 0.5-7.8
Liver / intrahepatic bile duct 4.0 7.8 4.6-12.4 3.2 12.3 6.8-20.7 0.8 2.6 0.7-7.9 3.2 5.8 3.3-9.8 2.4 8.6 4.3-15.8 0.8 2.5 0.7-7.6
Pancreas 9.2 17.1 12.4-23.1 5.2 19.1 12.3-28.7 4.0 14.6 8.9-23.2 6.8 12.6 8.7-18.0 3.2 11.8 6.5-19.8 3.6 13.5 7.9-22.1
Larynx 1.8 3.1 1.4-6.2 1.4 4.8 1.9-10.7 0.4 1.4 0.2-6.3 1.2 2.4 0.9-5.5 0.8 3.3 0.9-9.0 0.4 1.5 0.2-6.5
Lung and bronchus 37.4 66.7 57.3-77.4 20.8 75.3 61.1-92.1 16.6 58.0 46.0-72.7 22.2 40.8 33.4-49.5 11.6 44.7 33.6-58.6 10.6 37.0 27.6-49.1
Melanoma of the skin 15.2 28.9 22.6-36.7 10.2 37.2 27.4-49.7 5.0 22.7 14.2-34.5 2.2 4.2 2.0-7.8 1.4 5.9 2.2-12.7 0.8 3.5 0.9-9.6
Female breast             40.0 163.2 140.1-189.2             5.2 18.8 12.2-28.3
Cervix uteri             2.0 9.2 4.1-17.9             0.4 1.5 0.2-6.5
Corpus uterus and NOS             11.0 41.1 30.8-54.2             1.8 6.2 2.8-12.6
Ovary             2.2 8.6 4.1-16.5             2.0 7.5 3.5-14.6
Prostate       42.2 144.4 124.9-166.4             4.8 22.8 14.4-34.3      
Testis       1.0 4.4 1.4-10.5             0.0 0.0 0.0-3.8      
Urinary bladder (incl. in situ) 13.0 25.6 19.6-32.9 11.2 48.3 36.1-63.4 1.8 6.6 3.0-13.4 2.4 5.1 2.6-9.0 2.2 10.8 5.3-19.5 0.2 0.9 0.0-5.6
Kidney and renal pelvis 8.8 17.4 12.5-23.8 7.0 28.3 19.4-40.1 1.8 6.8 3.1-13.8 1.6 2.9 1.2-6.1 1.2 4.6 1.6-10.7 0.4 1.8 0.2-7.2
Brain and other central nervous system 2.6 5.5 2.8-9.7 1.4 5.7 2.1-12.4 1.2 5.0 1.7-11.9 2.2 3.7 1.8-7.1 1.2 3.4 1.2-8.4 1.0 3.9 1.1-10.1
Thyroid 8.0 16.6 11.7-23.1 2.0 7.5 3.5-14.5 6.0 28.5 18.6-41.8 0.0 0.0 0.0-2.0 0.0 0.0 0.0-3.8 0.0 0.0 0.0-4.2
Hodgkin lymphoma 1.4 3.1 1.2-6.7 0.8 3.5 0.9-9.3 0.6 2.5 0.4-8.3 0.2 0.4 0.0-2.7 0.0 0.0 0.0-3.8 0.2 0.9 0.0-5.6
Non-Hodgkin lymphomas 12.8 24.7 18.9-31.9 6.8 26.4 18.0-37.7 6.0 25.2 16.6-37.0 3.2 6.3 3.6-10.5 2.2 10.1 4.9-18.4 1.0 4.2 1.3-10.6
Myeloma 3.4 6.4 3.7-10.5 2.0 8.2 3.8-15.7 1.4 5.1 1.9-11.5 2.4 4.9 2.5-8.8 0.8 3.3 0.8-8.9 1.6 6.4 2.7-13.4
Leukemias 10.2 19.1 14.1-25.5 7.2 29.0 19.9-41.0 3.0 11.5 6.2-19.8 3.0 5.9 3.3-10.0 1.4 5.8 2.3-12.5 1.6 6.1 2.6-12.9

Notes

  • Incidence data are provisional, November 2021.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.